Scarica l'app Stockscreener
12.21
2.32%
-0.29
Dopo l'orario di chiusura:
12.00
-0.21
-1.72%
Alpha Tau Medical Ltd Borsa (DRTS) Ultime notizie
Alpha Tau Medical (DRTS) Clinical Win Puts Its Pricey Valuation Back In Focus - simplywall.st
Alpha Tau Medical Ltd (DRTS) Cash Flow - TradingKey
DRTS|Alpha Tau Medical Ltd|Price:12.690| - TradingKey
Alpha Tau Medical Ltd (DRTS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This Week - Stocktwits
Alpha Tau Medical (DRTS) Is Down 7.7% After Reporting 100% Response In Alpha DaRT Combo Study - simplywall.st
Enterprise value to EBIT forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
DRTS|Alpha Tau Medical Ltd|Price:12.500|Chg%:-0.740 - TradingKey
Alpha Tau Medical Ltd. Revenue Breakdown – NASDAQ:DRTS - TradingView
Enterprise value to EBITDA forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
Enterprise value to revenue forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
H.C. Wainwright reiterates Alpha Tau Medical stock rating at buy - Investing.com
H.C. Wainwright reiterates Alpha Tau Medical stock rating at buy By Investing.com - Investing.com UK
Alpha Tau Medical Ltd. (DRTS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alpha Tau Medical's (DRTS) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
Alpha Tau Medical Ltd. (DRTS) stock price, news, quote and history - Yahoo Finance UK
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $15 - Moomoo
DRTS Stock Price, Quote & Chart - ChartMill
Alpha Tau reports positive trial results for cancer therapy combo By Investing.com - Investing.com Nigeria
Alpha Tau rises on Alpha DaRT head and neck cancer data - Seeking Alpha
Alpha Tau Posts Strong Alpha DaRT–Keytruda Data in Head and Neck Cancer Study - TipRanks
Alpha Tau reports positive trial results for cancer therapy combo - Investing.com
100% cancer response in Alpha DaRT trial for Alpha Tau Medical (Nasdaq: DRTS) - Stock Titan
All 9 Evaluable Patients Responded in Alpha Tau Cancer Trial - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Alpha Tau Medical (DRTS) Reaches ADMIRE Milestone, Is The Stock Now Fully Valued? - simplywall.st
H.C. Wainwright reiterates Alpha Tau Medical stock rating on immunocompromised patient treatment By Investing.com - Investing.com South Africa
Alpha Tau Medical (DRTS) Is Up 6.6% After First Immunocompromised cSCC Patient Treated With Alpha DaRT - simplywall.st
H.C. Wainwright reiterates Alpha Tau Medical stock rating on immunocompromised patient treatment - Investing.com Nigeria
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
DRTS Reiterated by HC Wainwright & Co. -- Price Target Maintained at $15 - GuruFocus
Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center - The Manila Times
Alpha Tau Medical (Nasdaq: DRTS) treats first ADMIRE trial patient with Alpha DaRT - Stock Titan
Alpha Tau Successfully Treats First Immunocompromised - GlobeNewswire
Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $17 - Moomoo
Top Executive Makes Bold Move in Alpha Tau Medical’s Latest Insider Trade - TipRanks
Alpha Tau Medical stock tracks a thin session. Investors watch its listing and filings. - ad-hoc-news.de
Alpha Tau Medical: Alpha Particles Are Still Interesting, But Beware The Hype (NASDAQ:DRTS) - Seeking Alpha
Alpha Tau Medical (DRTS) CFO trades 2,270 shares in exercise and sale - Stock Titan
Enterprise value to revenue forward of Alpha Tau Medical Ltd. – NASDAQ:DRTS - TradingView
Price to sales forward of Alpha Tau Medical Ltd. – BOATS:DRTS - TradingView
Price to earnings forward of Alpha Tau Medical Ltd. – NASDAQ:DRTS - TradingView
Major Insider Move at Alpha Tau Medical Shakes Up Investor Buzz - TipRanks
Enterprise value to EBIT forward of Alpha Tau Medical Ltd. – NASDAQ:DRTS - TradingView
Insider Sell: Raphi Levy Sells Shares of Alpha Tau Medical Ltd (DRTS) - GuruFocus
Enterprise value to EBITDA forward of Alpha Tau Medical Ltd. – BOATS:DRTS - TradingView
Alpha Tau Medical (DRTS) Is Up 17.9% After First International Alpha DaRT Glioblastoma Procedure – Has The Bull Case Changed? - simplywall.st
Form 144 Alpha Tau Medical Ltd. For: 6 July By Investing.com - Investing.com Nigeria
Alpha Tau Medical (DRTS) notice: 20,000 shares from option exercise to be sold - Stock Titan
Alpha Tau Medical (DRTS) CFO exercises 17,873 options and sells 17,873 shares - Stock Titan
Alpha Tau Medical (DRTS) price target increased by 15.15% to 9.69 - MSN
Alpha Tau Medical (NASDAQ: DRTS) CFO sells 2,127 shares after exercising options - Stock Titan
Form 144 Alpha Tau Medical Ltd. For: 2 July By Investing.com - Investing.com Nigeria
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):